BridgeMD
New treatment option for Liver Transplant; Complications
Official title HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
ClinicalTrials.gov ID: NCT06386198
What this study is testing
- What it's testing
- The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 25
You may be able to join if
- Patient has received a liver transplant \>1 year ago
- Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
- Patient has an unmet social risk (e.g., food insecurity) or MLVI \>/= 2.0.
- Patient will be transferred to adult transplant team in \<6 months.
- Patient can read and write English or Spanish
You likely can't join if
- Patient has significant cognitive impairment.
- Does not meet age criteria
- Patient is a ward of the state.
- Non-English, non-Spanish speakers.
- Non-US residents.
See the full eligibility criteria
- Patient has received a liver transplant \>1 year ago
- Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
- Patient has an unmet social risk (e.g., food insecurity) or MLVI \>/= 2.0.
- Patient will be transferred to adult transplant team in \<6 months.
- Patient can read and write English or Spanish
- Patient is between 18-25 years old and can provide informed consent.
- Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.
- Patient has significant cognitive impairment.
- Does not meet age criteria
- Patient is a ward of the state.
- Non-English, non-Spanish speakers.
- Non-US residents.
The study team makes the final eligibility decision.
Where it's taking place
- San Francisco, California, United States
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Francisco, California, United States; Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.